Shandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) Plans to Acquire 100% Equity of Shandong Weigao Puraid Medical Packaging Co., Ltd.; Trading Resumes

Stock News10-31

Shandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) announced its plan to issue shares for the acquisition of 100% equity in Shandong Weigao Puraid Medical Packaging Co., Ltd. ("Weigao Puraid") held by Weigao Group, Weihai Shengxi, and Weihai Ruiming. The company's shares will resume trading on Monday, November 3, 2025.

Upon completion of the transaction, the company aims to expand its product line into the pharmaceutical packaging materials sector by integrating Weigao Puraid's technological expertise and product portfolio. Additionally, the deal will leverage the listed company's hollow fiber filtration technology and Weigao Puraid's extensive customer resources in the biopharmaceutical field, enabling mutual enhancement in product technology and sales channels for biopharmaceutical filtration businesses. This collaboration is expected to drive growth in the upstream biopharmaceutical market, with a focus on biopharmaceutical filtration products.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123377916?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 19:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123377916","market":"hk","top_or_hot":-1,"title":"Shandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) Plans to Acquire 100% Equity of Shandong Weigao Puraid Medical Packaging Co., Ltd.; Trading Resumes","media":"Stock News","content":"<p>Shandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) announced its plan to issue shares for the acquisition of 100% equity in Shandong Weigao Puraid Medical Packaging Co., Ltd. (\"Weigao Puraid\") held by Weigao Group, Weihai Shengxi, and Weihai Ruiming. The company's shares will resume trading on Monday, November 3, 2025.</p>\n<p>Upon completion of the transaction, the company aims to expand its product line into the pharmaceutical packaging materials sector by integrating Weigao Puraid's technological expertise and product portfolio. Additionally, the deal will leverage the listed company's hollow fiber filtration technology and Weigao Puraid's extensive customer resources in the biopharmaceutical field, enabling mutual enhancement in product technology and sales channels for biopharmaceutical filtration businesses. This collaboration is expected to drive growth in the upstream biopharmaceutical market, with a focus on biopharmaceutical filtration products.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) Plans to Acquire 100% Equity of Shandong Weigao Puraid Medical Packaging Co., Ltd.; Trading Resumes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) Plans to Acquire 100% Equity of Shandong Weigao Puraid Medical Packaging Co., Ltd.; Trading Resumes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-10-31 19:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) announced its plan to issue shares for the acquisition of 100% equity in Shandong Weigao Puraid Medical Packaging Co., Ltd. (\"Weigao Puraid\") held by Weigao Group, Weihai Shengxi, and Weihai Ruiming. The company's shares will resume trading on Monday, November 3, 2025.</p>\n<p>Upon completion of the transaction, the company aims to expand its product line into the pharmaceutical packaging materials sector by integrating Weigao Puraid's technological expertise and product portfolio. Additionally, the deal will leverage the listed company's hollow fiber filtration technology and Weigao Puraid's extensive customer resources in the biopharmaceutical field, enabling mutual enhancement in product technology and sales channels for biopharmaceutical filtration businesses. This collaboration is expected to drive growth in the upstream biopharmaceutical market, with a focus on biopharmaceutical filtration products.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0251","symbol_name":"专用设备","start_time":0,"source_url":"","article_id":"1123377916","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123377916","pubTimestamp":1761909375,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) announced its plan to issue shares for the acquisition of 100% equity in Shandong Weigao Puraid Medical Packaging Co., Ltd. (\"Weigao...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603014":"威高血净","BK0251":"专用设备"},"translate_title":"山东威高血液净化制品有限公司。（603014.SH）拟收购山东威高普瑞德医用包装有限公司100%股权；交易恢复","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603014":1},"content_text":"Shandong Weigao Blood Purification Products Co.,Ltd. (603014.SH) announced its plan to issue shares for the acquisition of 100% equity in Shandong Weigao Puraid Medical Packaging Co., Ltd. (\"Weigao Puraid\") held by Weigao Group, Weihai Shengxi, and Weihai Ruiming. The company's shares will resume trading on Monday, November 3, 2025.\nUpon completion of the transaction, the company aims to expand its product line into the pharmaceutical packaging materials sector by integrating Weigao Puraid's technological expertise and product portfolio. Additionally, the deal will leverage the listed company's hollow fiber filtration technology and Weigao Puraid's extensive customer resources in the biopharmaceutical field, enabling mutual enhancement in product technology and sales channels for biopharmaceutical filtration businesses. This collaboration is expected to drive growth in the upstream biopharmaceutical market, with a focus on biopharmaceutical filtration products.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123377916","isCrawlerRequest":true}